BR9912024A - Emplastros em gel contento esteróide e processo para a produção dos mesmos - Google Patents

Emplastros em gel contento esteróide e processo para a produção dos mesmos

Info

Publication number
BR9912024A
BR9912024A BR9912024-0A BR9912024A BR9912024A BR 9912024 A BR9912024 A BR 9912024A BR 9912024 A BR9912024 A BR 9912024A BR 9912024 A BR9912024 A BR 9912024A
Authority
BR
Brazil
Prior art keywords
production
steroid
blended
weight
containing steroid
Prior art date
Application number
BR9912024-0A
Other languages
English (en)
Inventor
Kazunori Muta
Seiichiro Tsuru
Taro Yamahata
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of BR9912024A publication Critical patent/BR9912024A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Abstract

Patente de Invenção: <B>"EMPLASTROS EM GEL CONTENDO ESTERóIDE E PROCESSO PARA A PRODUçãO DOS MESMOS"<D>. Emplastro em gel contendo esteróide contendo um esteróide como um ingrediente eficaz a 0,005 a 0,05% em peso, crotamitona como um estabilizador a 15% em peso ou menos e um tensoativo em uma base, onde a quantidade da crotamitona misturada é de 200 a 3000 vezes o peso do esteróide misturado e a quantidade do tensoativo misturado é de 1/20 a 1/5 vezes o peso da crotamitona misturada.
BR9912024-0A 1998-07-10 1999-07-07 Emplastros em gel contento esteróide e processo para a produção dos mesmos BR9912024A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19593398A JP4456679B2 (ja) 1998-07-10 1998-07-10 ステロイド含有パップ剤及びその製造方法
PCT/JP1999/003673 WO2000002563A1 (fr) 1998-07-10 1999-07-07 Cataplasmes contenant des steroides et procede de fabrication associe

Publications (1)

Publication Number Publication Date
BR9912024A true BR9912024A (pt) 2001-05-29

Family

ID=16349396

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912024-0A BR9912024A (pt) 1998-07-10 1999-07-07 Emplastros em gel contento esteróide e processo para a produção dos mesmos

Country Status (11)

Country Link
US (1) US6432431B1 (pt)
EP (1) EP1097712B1 (pt)
JP (1) JP4456679B2 (pt)
KR (1) KR20010072664A (pt)
CN (1) CN1308537A (pt)
AT (1) ATE250930T1 (pt)
BR (1) BR9912024A (pt)
DE (1) DE69911788T2 (pt)
ES (1) ES2209456T3 (pt)
ID (1) ID27765A (pt)
WO (1) WO2000002563A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3655781B2 (ja) * 1999-08-25 2005-06-02 帝國製薬株式会社 ビタミンｃ又はその誘導体を配合したパップ剤
JP5300038B2 (ja) * 2000-03-07 2013-09-25 株式会社 資生堂 皮膚外用剤
WO2001087244A1 (fr) * 2000-05-15 2001-11-22 Hisamitsu Pharmaceutical Co., Inc. Paquets de lingettes
CN1431906A (zh) * 2000-05-31 2003-07-23 日绊株式会社 透皮吸收型甾体外用药
WO2001095889A1 (fr) * 2000-06-13 2001-12-20 Hisamitsu Pharmaceutical Co., Inc. Platre
US7993654B2 (en) 2002-12-23 2011-08-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract
DE10260873A1 (de) 2002-12-23 2004-07-15 Beiersdorf Ag Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
DE10260872B4 (de) * 2002-12-23 2013-09-26 Beiersdorf Ag Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices
WO2004066985A1 (ja) * 2003-01-28 2004-08-12 Teikoku Seiyaku Co., Ltd. 薄型水性貼付剤
JP4703559B2 (ja) * 2004-04-28 2011-06-15 久光製薬株式会社 貼付剤
JP4744439B2 (ja) * 2004-04-28 2011-08-10 久光製薬株式会社 貼付剤
JP4824337B2 (ja) * 2004-05-07 2011-11-30 ロート製薬株式会社 皮膚外用剤
JP4824336B2 (ja) * 2004-05-07 2011-11-30 ロート製薬株式会社 皮膚外用剤
EP1806152B1 (en) * 2004-11-10 2012-08-01 Hisamitsu Pharmaceutical Co., Inc. Drug for external use and adhesive patch
CN103830179B (zh) * 2014-03-24 2015-11-18 段懿玲 一种含有克罗米通的外用制剂及其制备工艺
CN104984385B (zh) * 2015-07-23 2017-08-29 山东维赫生物科技有限公司 一种水溶性医用预粘剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5842168B2 (ja) * 1974-12-20 1983-09-17 トウコウヤクヒンコウギヨウ カブシキガイシヤ 局所用剤の製造方法
JPS5850964B2 (ja) * 1978-03-07 1983-11-14 東興薬品工業株式会社 ステロイド含有クリ−ム製剤およびその製造方法
JPS58225009A (ja) * 1982-06-23 1983-12-27 Shionogi & Co Ltd コルチコステロイド外用製剤
JPH0236572B2 (ja) * 1984-11-13 1990-08-17 Hokuriku Pharmaceutical Suteroidoo177monoesuteruganjukuriimuzai
JPS6351330A (ja) * 1986-08-20 1988-03-04 Teikoku Seiyaku Kk ステロイド剤含有外用貼付剤
JPS63201119A (ja) * 1987-02-17 1988-08-19 Kao Corp 貼付剤組成物
JPH0676327B2 (ja) * 1987-04-14 1994-09-28 株式会社大塚製薬工場 ステロイド軟膏製剤
JPH05271077A (ja) * 1992-03-25 1993-10-19 Lion Corp パップ剤
JP3029964B2 (ja) * 1993-01-20 2000-04-10 久光製薬株式会社 ステロイド類溶解剤及びステロイド類を主剤とする外用液剤
JP2860748B2 (ja) * 1993-12-24 1999-02-24 エスエス製薬株式会社 安定な酪酸ヒドロコルチゾン含有クリーム剤
JPH0853354A (ja) * 1994-08-11 1996-02-27 Hisamitsu Pharmaceut Co Inc 皮膚疾患用水性貼付剤
EP0787488A4 (en) * 1994-11-18 1998-06-03 Hisamitsu Pharmaceutical Co TRANSDERMAL ABSORBABLE PLASTER

Also Published As

Publication number Publication date
ATE250930T1 (de) 2003-10-15
ID27765A (id) 2001-04-26
EP1097712A1 (en) 2001-05-09
EP1097712B1 (en) 2003-10-01
DE69911788D1 (de) 2003-11-06
KR20010072664A (ko) 2001-07-31
DE69911788T2 (de) 2004-05-06
US6432431B1 (en) 2002-08-13
ES2209456T3 (es) 2004-06-16
CN1308537A (zh) 2001-08-15
JP4456679B2 (ja) 2010-04-28
WO2000002563A1 (fr) 2000-01-20
JP2000026299A (ja) 2000-01-25
EP1097712A4 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
BR9912024A (pt) Emplastros em gel contento esteróide e processo para a produção dos mesmos
BR9607565A (pt) Derivados de hidroxilamina úteis para produção de protetores moleculares e sua preparação
PT1311285E (pt) Composicao farmaceutica liquida contendo um derivado de eritropoietina
BR9406080A (pt) Compostos que tem tanto antividade de anaonista potente de calcio como de antioxidante e uso dos mesmos como agentes citoprotetores
BRPI0416752A (pt) composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
BRPI0411500A (pt) pesticida para aplicar um aniquilamento de modo de ação fìsica, composição hidrocoloidal, método de aniquilamento de pestes em plantas pelo modo fìsico de operação e processo para a preparação de um pesticida
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
BR9807145A (pt) 2-metoxiimino-2-(piridiniloximetil) fenilacetamidas com derivados de ácido carboxìlico no anel de piridina como fungicidas.
BR9808956A (pt) Composição pesticida
AR016044A1 (es) Composiciones farmaceuticas que comprenden cantidades antialergenicas efectivas de descarboniletoxiloratadina
DK0742214T3 (da) I hjerte-kar-systemet aktive, nye seco-D steroider samt farmaceutiske præparater indeholdende sådanne
BR0312179A (pt) Processo para preparação de derivado de epik5-n-o-supersulfato, composição farmacêutica e composição cosmética contendo o mesmo e seu uso
DE69801811D1 (de) Alkykendiamin di- oder tri-essigsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in kosmetischen zusammensetzungen
BR0308633A (pt) Composições, métodos para bioestimular as agrìcolas, e, uso das composições
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
EE04952B1 (et) Ravimkoostis ja meetod selle valmistamiseks
IT1215340B (it) Derivati di esteri dell&#39;acido immidazol-1-il-carbossilico, procedimenti per la loro preparazione e composizioni fungicide che contengono il derivato come componente attivo.
AR026756A1 (es) Nuevas combinaciones terapeuticas (s)-2-bencilamino-metil)-2,3,8,9-tetrahidro-7h-1,4-dioxino[2,3-e]indol-8-ona y neuroleticos para el tratamiento oprevencion de desordenes psicoticos
PT986390E (pt) Composicoes farmaceuticas que contem cicloridrato de cinchonina
BR9907208A (pt) &#34;pré-mistura aditivada para produtos alimentìcios&#34;
IT1307866B1 (it) Composizioni farmaceutiche contenenti inibitori dell&#39;ormone dellacrescita o loro frammenti biologicamente attivi per il trattamento

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.